EMUGEN
Live / Applied — New application — not yet assigned to an examiner (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 31 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99735877
- Mark type
- Stylized text
- Filed
- 31 Mar 2026
- Attorney of record
- Karen K. Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations, namely, gene therapy products for the treatment of Rett Syndrome, Dravet Syndrome, neurological diseases and disorders, central nervous system disease and disorders, and genetic diseases and disorders; Pharmaceutical preparations for gene replacement and gene regulation in diseases, disorders, and conditions affecting the brain and central nervous system; Drug delivery agents, namely, bioengineered adeno-associated virus vectors for delivering gene therapies across blood-brain barrier
- Class 042 — Scientific and technological services: Scientific research and development of new technologies and products in the field of gene therapy, neurology, neurobiology, and genetic medicine; Bioengineering of adeno-associated virus vectors for use in gene therapy, and other gene regulation and gene replacement technologies; Providing scientific research information in the field of gene therapy, neurology, neurobiology, genetic medicine, and drug delivery across blood-brain barrier
Owner
- Emugen Therapeutics LLC, Woburn, MA, US
Prosecution history
- 31 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 31 Mar 2026 — NEW APPLICATION ENTERED